English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

BeiGene Raises more than $150 million in NASDAQ IPO

Feb. 3, 2016

BeiGene, a drug company developing immuno-oncology drugs for cancer treatments has sold 6.6 million shares at an issue price of $24, to raise about $158 million. Goldman, Sachs, Morgan Stanley and Cowen and Company were the underwriters for the offering.